Using an in vitro xenoantibody-mediated complement-dependent cytotoxicity model to evaluate the complement inhibitory activity of the peptidic C3 inhibitor Cp40
The in vitro xenoantibody-mediated CDC assay was shown to be reliable and translational to evaluate the complement inhibitory activity of peptidic C3 inhibitors.
•
More deposition of C4 fragments on iPECs was detected in the Cp40-pretreated group than that in Cp40-untreated group.
•
Effects of Cp40 on complement activation in humans and NHPs had an overall similar inhibitory pattern.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.